LSAE Publication Sources Tool

De Sole G, Remme J. Importance of migrants infected with Onchocerca volvulus in west African river valleys protected by 14 to 15 years of Simulium control. Trop Med Parasitol. 1991; 42(2): 75–8.

De Sole G, Remme J. Importance of migrants infected with Onchocerca volvulus in west African river valleys protected by 14 to 15 years of Simulium control. Trop Med Parasitol. 1991; 42(2): 75–8.

Sáez-Llorens X, Castaño E, Wubbel L, Castrejón MM, de Morales I, Vallarino D, de Atencio I, Muñiz L, Olsen K, McCracken GH. Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia. Rev Med Panama. 1998; 23(2): 27-33.

Sáez-Llorens X, Castaño E, Wubbel L, Castrejón MM, de Morales I, Vallarino D, de Atencio I, Muñiz L, Olsen K, McCracken GH. Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia. Rev Med Panama. 1998; 23(2): 27-33.

Sáez-Llorens X, Castaño E, Wubbel L, Castrejón MM, de Morales I, Vallarino D, de Atencio I, Muñiz L, Olsen K, McCracken GH. Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia. Rev Med Panama. 1998; 23(2): 27-33.

Kamga GR, Dissak-Delon FN, Nana-Djeunga HC, Biholong BD, Ghogomu SM, Souopgui J, Kamgno J, Robert A. Important progress towards elimination of onchocerciasis in the West Region of Cameroon. Parasites Vectors. 2017; 10(1): 373.

Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010; 115(17): 3447-52.

Romeo R, Zala D, Knapp M, Orrell M, Fossey J, Ballard C. Improving the quality of life of care home residents with dementia: Cost-effectiveness of an optimized intervention for residents with clinically significant agitation in dementia. Alzheimers Dement. 2019; 15(2): 282-291.

Warszawski J, Bajos N, Meyer L, de Lamballerie X, Seng R, Beaumont A, Slama R, Hisbergues M, Rahib D, Lydie N, Legendre B, Barlet M, Rey S, Raynaud P, Leduc A, Costemalle V, Beck F, Legleye S, Castell L, Givord P, Favre-Martinoz C, Paliod N, Sihol J, Sillard P. In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2. Études et Résultats. 2020; (1167): 1-6.

Hashem AA, Abd El Fadeal NM, Shehata AS. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital. J Med Microbiol. 2017; 66(6): 744-752.

Hashem AA, Abd El Fadeal NM, Shehata AS. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital. J Med Microbiol. 2017; 66(6): 744-752.

Lari AR, Validi N, Ghaffarzadeh K, Shamshiri AR. In vitro activity of cefixime versus ceftizoxime against Salmonella typhi. Pathol Biol. 1997; 45(5): 415-9.

Jean SS, Lu MC, Shi ZY, Tseng SH, Wu TS, Lu PL, Shao PL, Ko WC, Wang FD, Hsueh PR. In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Infect. 2018; 11: 1983-92.

Biedenbach DJ, Badal RE, Huang MY, Motyl M, Singhal PK, Kozlov RS, Roman AD, Marcella S. In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study. Infect Dis Ther. 2016; 5(2): 139-53.

Qadri SM, Ueno Y, Almodovar E. In vitro activity of sparfloxacin against Salmonella typhi. Chemotherapy. 1997; 43(1): 6-9.

Mohamed NM, Youssef AA. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt. Microb Drug Resist. 2011; 17(4): 489-95.

Mohamed NM, Youssef AA. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt. Microb Drug Resist. 2011; 17(4): 489-95.

Lesmana M, Lebron CI, Taslim D, Tjaniadi P, Subekti D, Wasfy MO, Campbell JR, Oyofo BA. In vitro antibiotic susceptibility of Neisseria gonorrhoeae in Jakarta, Indonesia. Antimicrob Agents Chemother. 2001; 45(1): 359-62.

Roland RK, Mendes RE, Silbert S, Bolsoni AP, Sader HS. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams. Braz J Infect Dis. 2000; 4(5): 226-35.

Malik N, Ahmed M. In vitro effect of new antibiotics against clinical isolates of Salmonella Typhi. J Coll Physicians Surg Pak. 2016; 26(4): 288-92.

Bakthavatchalam YD, Kumar DT, Tayubi IA, Shankar BA, Babu P, Munusamy E, Thukkaram B, Ravi R, Doss CGP, Veeraraghavan B. In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection. J Appl Microbiol. 2017; 123(3): 615-24.

Kiliç H, Karahan M. In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics. Mikrobiyol Bul. 1991; 25(1): 28-35.

Berron S, Vazquez JA, Gimenez MJ, e la Fuente L, Aguilar L. In vitro susceptibilities of 400 Spanish isolates of Neisseria gonorrhoeae to gemifloxacin and 11 other antimicrobial agents. Antimicrob Agents Chemother. 2000; 44(9): 2543-4.

Dorlencourt F, Boireaux C, Sednaoui P, Danilenko NV, Legros D. In vitro susceptibility of 120 strains of Neisseria gonorrhoeae isolated in Kyrghyzstan. Sex Transm Dis. 2002; 29(7): 376-8.

Furuya R, Nakayama H, Kanayama A, Saika T, Iyoda T, Tatewaki M, Matsuzaki K, Kobayashi I, Tanaka M. In vitro synergistic effects of double combinations of -lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. J Infect Chemother. 2006; 12(4): 172-6.